Ann: OLE Study update reveals impressive Survival Data, page-132

From my reading of various announcements, first not all patients were on actual same dosage but the dosage was determined by body weight.
2mgs / kg cohort 1 first patient dosed 3/10/2022 and last patient dosed 2/12/2022 - there was a delay due to one patient needing to be replace account a compliance issue.
These patients remained on the 2mgs/kg until they moved onto cohort 3 dosage of 6mgs/kg around 9/6/2023, which I believe they remained on until starting the extension trial.

Cohort 2 patients commenced on 4mgs/kg around 20/1/2023 until they moved to cohort 4 around 13/10/2023 with a dosage of 10mgs/kg which they have remained on as the extension trial dosage being 10mgs/kg